filmov
tv
Ruxolitinib
Показать описание
How to pronounce Ruxolitinib
Pharma Guru
Рекомендации по теме
0:07:33
How Long Should Patients Take Jakafi® (ruxolitinib)?
0:03:40
Pros and cons of ruxolitinib for the treatment of MPNs
0:04:31
Ruxolitinib for Treatment of Polycythemia Vera
0:01:56
Ruxolitinib in 2020 and beyond
0:02:10
Management of ruxolitinib failure in myelofibrosis
0:04:17
PV: Treatment With Ruxolitinib
0:07:43
Exploring a Therapy Called Jakafi® (ruxolitinib)
0:02:07
Real-world use of ruxolitinib in patients with myelofibrosis with anemia or thrombocytopenia
0:01:20
The impact of early ruxolitinib treatment on OS in the COMFORT-I and COMFORT-II studies
0:01:11
Pacritinib vs Ruxolitinib
0:01:55
Ruxolitinib Cream for Vitiligo | NEJM
0:01:58
The ongoing use of ruxolitinib in myelofibrosis
0:01:42
Momelotinib vs. ruxolitinib in myelofibrosis patients with thrombocytopenia
0:06:44
How does Jakafi® (ruxolitinib) work?
0:01:23
RESPONSE-2 5-year follow-up update: ruxolitinib vs BAT in polycythemia vera without splenomegaly
0:01:15
Reviewing the role and efficacy of ruxolitinib in myelofibrosis ten years after its approval
0:03:56
An update on MANIFEST: pelabresib monotherapy or as add-on to ruxolitinib in myelofibrosis
0:05:21
Mechanism of JAK Inhibitors and a Review of Ruxolitinib
0:02:51
Approval of Ruxolitinib: Steroid-Refractory Acute GVHD
0:02:09
MAJIC update: promising results for ruxolitinib in PV and ET
0:00:46
Safety of treating myelofibrosis with ruxolitinib – results from JUMP trial
0:01:38
The characteristics of patients with myelofibrosis taking ruxolitinib for 3 or more years
0:08:57
What Are the Common Side Effects of Jakafi® (ruxolitinib)?
0:02:29
Ruxolitinib and ibrutinib: the future for GvHD treatment?
0:07:33
0:03:40
0:04:31
0:01:56
0:02:10
0:04:17
0:07:43
0:02:07
0:01:20
0:01:11
0:01:55
0:01:58
0:01:42
0:06:44
0:01:23
0:01:15
0:03:56
0:05:21
0:02:51
0:02:09
0:00:46
0:01:38
0:08:57
0:02:29